Amigo-Jiménez, Irene Bailón, Elvira Ugarte-Berzal, Estefanía Aguilera-Montilla, Noemí A. García-Marco, José García-Pardo, Angeles Clinical characteristics of CLL patients. a<p>Clinical stage according to references <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0099993#pone.0099993-Zenz1" target="_blank">[1]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0099993#pone.0099993-Gaidano1" target="_blank">[2]</a>.</p>b<p>Percentage of cells expressing this marker.</p>c<p>The coexpression of CD38 and ZAP-70 has clinical prognostic value <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0099993#pone.0099993-Zenz1" target="_blank">[1]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0099993#pone.0099993-Gaidano1" target="_blank">[2]</a>.</p><p>ND, not determined.</p> cell biology;Cell processes;Cell death;Cellular stress responses;Signal transduction;cell signaling;Signaling cascades;Apoptotic signaling cascade;Anti-apoptotic signaling;Apoptotic signaling;Molecular cell biology;immunology;Clinical immunology;immunopathology;hematology;Hematologic cancers and related disorders;leukemias;Lymphoblastic leukemia;Chronic lymphoblastic leukemia;cll 2014-06-23
    https://plos.figshare.com/articles/dataset/_Clinical_characteristics_of_CLL_patients_/1067492
10.1371/journal.pone.0099993.t001